跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIFAREN 150 CAPSULE 150 mg - HSA Drug Approval Details
Approvals
/
HSA
/
RIFAREN 150 CAPSULE 150 mg
Approved
THERAPEUTIC
RIFAREN 150 CAPSULE 150 mg
REMEDICA LTD
🇸🇬 Health Sciences Authority
Approval Date
Apr 21, 1988
Approval ID
a1437484658af4ac
Company
REMEDICA LTD
Type
Therapeutic
Approval Details
Approval Id
a1437484658af4ac
Drug Name
RIFAREN 150 CAPSULE 150 mg
Product Name
RIFAREN 150 CAPSULE 150 mg
Approval Number
SIN00312P
Approval Date
1988-04-21
Registrant
GOLDPLUS UNIVERSAL PTE LTD
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
CAPSULE
Route Of Administration
ORAL
Atc Code
J04AB02
Atc Item Name
rifampicin
Pharma Manufacturer Name
GOLDPLUS UNIVERSAL PTE LTD
Company Detail Path
/organization/goldplus-universal-pte-ltd
Active Ingredients
RIFAMPICIN
150 mg
RIFAMPICIN
150 mg
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 21, 1988
Approval ID
a1437484658af4ac
Type
Therapeutic
Back to HSA Approvals